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Abstract
Background: Infectious pancreatic necrosis virus (IPNV) is an aquatic member of the Birnaviridae family that causes
widespread disease in salmonids. IPNV is represented by multiple strains with markedly different virulence.
Comparison of isolates reveals hyper variable regions (HVR), which are presumably associated with pathogenicity.
However little is known about the rates and modes of sequence divergence and molecular mechanisms that
determine virulence. Also how the host response may influence IPNV virulence is poorly described.
Methods: In this study we compared two field isolates of IPNV (NFH-Ar and NFH-El). The sequence changes,
replication and mortality were assessed following experimental challenge of Atlantic salmon. Gene expression
analyses with qPCR and microarray were applied to examine the immune responses in head kidney.
Results: Significant differences in mortality were observed between the two isolates, and viral load in the pancreas
at 13 days post infection (d p.i.) was more than 4 orders of magnitude greater for NFH-Ar in comparison with NFH-
El. Sequence comparison of five viral genes from the IPNV isolates revealed different mutation rates and Ka/Ks
ratios. A strong tendency towards non-synonymous mutations was found in the HRV of VP2 and in VP3. All
mutations in VP5 produced precocious stop codons. Prior to the challenge, NFH-Ar and NFH-El possessed high and
low virulence motifs in VP2, respectively. Nucleotide substitutions were noticed already during passage of viruses in
CHSE-214 cells and their accumulation continued in the challenged fish. The sequence changes were notably
directed towards low virulence. Co-ordinated activation of anti-viral genes with diverse functions (IFN-a1 and c,
sensors - Rig-I, MDA-5, TLR8 and 9, signal transducers - Srk2, MyD88, effectors - Mx, galectin 9, galectin binding
protein, antigen presentation - b2-microglobulin) was observed at 13 d p.i. (NFH-Ar) and 29 d p.i. (both isolates).
Conclusions: Mortality and expression levels of the immune genes were directly related to the rate of viral replication,
which was in turn associated with sequences of viral genes. Rapid changes in the viral genome that dramatically reduced
virus proliferation might indicate a higher susceptibility to protective mechanism employed by the host. Disease outbreak
and mortality depend on a delicate balance between host defence, regulation of signalling cascades and virus genomic
properties.
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Background
Despite vaccination programs, outbreaks of infectious
pancreatic necrosis disease (IPN) are frequent in farmed
salmon fry and post-smolts. Mortality rates observed in
outbreaks vary considerably and have in part been
ascribed to the inherited differences in susceptibility of
the host [1-3]. Environmental stress [4-7] and the viral
strains [8] also influence mortality. Atlantic salmon sur-
viving an IPNV infection may become asymptomatic car-
riers of the virus for long periods [9,10]. The production
of virus may increase under stress, and carriers can shed
the virus and infect surrounding fish [11].
The IPN virus (IPNV) is a bi-segmented double-
stranded RNA (dsRNA) virus in the family Birnaviri-
dae encoding 5 viral proteins. Segment B encodes the
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encodes a polyprotein which is cotranslationally
cleaved by the viral encoded serine-lysine protease
(VP4) releasing the proteins pVP2 and VP3 [12,13].
pVP2 is further processed by host cell proteases to
form the mature outer capsid protein VP2 [14], which
is the most abundant virus protein and contains the
antigenic regions responsible for induction of neutra-
lizing antibodies in the host [15]. VP3 is the inner
structural protein, which bound to dsRNA constitutes
the ribonucleoprotein core structure [16]. Additionally
VP3 is shown to bind VP1 and to self-associate
strongly, indicating that it is a matrix protein [17]. An
alternative open reading frame (ORF) on Segment A
encodes the small, arginine-rich, non-structural protein
VP5. The biological function of IPNV VP5 remains to
be determined.
The molecular basis of IPNV virulence and its interplay
with host antiviral mechanisms are not fully understood.
Sano and co-workers [18] were the first to suggest that the
virulence of IPNV is associated with Segment A. Several
studies using nucleotide sequence analyses have confirmed
this and have shown that the VP2 residues 217 and 221
are the major determinant of virulence of IPNV serotype
Sp strains. In addition, position 247 was seen as highly
variable [19]. Highly virulent isolates possess residues
Thr
217 and Ala
221; moderate- to low-virulence strains have
Pro
217 and Ala
221, while the strains containing Thr
221 are
almost avirulent, irrespectiveo ft h er e s i d u ea tp o s i t i o n
217. IPNV isolates also differ in properties related to repli-
cation rate and the ability to cause persistent infections.
These characteristics can be attributed to the same amino
acids as those determining the virulence [8]. Although
some of the factors behind these mechanisms are known
there are still many questions to be answered.
During viral infections the initial response of the
immune system is the induction of type I interferons
(IFN), which mediate antiviral and immunomodulatory
activity. In Atlantic salmon three different subtypes of type
I IFN have been identified: IFN-a, b and c [20]. IFN-a1
and c are both expressed in head kidney and are induced
by poly I:C [20]. IFN-a1 has been shown to provide pro-
tection against IPNV in salmonid cells [21,22]. The gen-
eration of anti-viral responses during infections requires a
rapid viral sensing by pattern recognition receptors
(PRRs). Toll-like receptors (TLRs) on the cell-surface or
within endosomes recognize single-stranded RNA
(ssRNA) and dsRNA [23], while the helicases RIG-I and
MDA5 recognize ssRNA and dsRNA in the cytosol [24].
Additionally, dsRNA are recognized by PKR [25]. A num-
ber of PRRs have been identified in Atlantic salmon
including RIG-I [26], MDA5 (GenBank: EG820831), PKR
(GenBank: EF523422), TLR3 [20], TLR8 [27], TLR9 [28]
and TLR22 (GenBank: CAJ80696[29] and FM206383).
The latter is a dsRNA-specific PRR found exclusively in
lower vertebrates [30]. Several studies have shown strong
activation of immune genes upon challenge with highly
virulent IPNV isolates [31,32], and type I IFNs and the
IFN-inducible Mx gene were among the most highly up-
regulated genes. However, it remains to find, which PRRs
are required for the induction of a systemic type I IFN
response during IPNV infections.
Little is known about the relationship between the host
responses and the virulence of different IPNV isolates.
The latter can be associated with either down-regulation
or excessive stimulation of innate immunity. Studies of
IPNV infected cell-lines [33,34] have shown inhibition of
IFN signaling. In the current work we have assessed
immune gene expression changes during an experimental
challenge of salmon post-smolts with both a virulent and
an avirulent IPNV field strain. In addition to quantitative
real-time RT PCR (qPCR) analyses of selected genes we
used cDNA microarray, which expanded the repertoire
of genes.
The two IPNV isolates used in this study were originally
collected from field outbreaks of IPN with 32% and 5%
reported mortality, respectively. Initial characterization of
the isolates in our lab showed that they both contained
the high virulent motif Thr
217 Ala
221 Thr
247 in VP2
defined by Santi et al [19]. A previous bath challenge per-
formed by our group included these isolates, and indicated
that they differed substantially in virulence levels reflecting
the field mortalities (unpublished). Sequencing of VP2
after this challenge confirmed the Thr
217 Ala
221 motif in
both isolates. However, propagation of the isolates in cell-
cultures before the challenge experiment reported here
changed the isolate with the initial low mortality to con-
tain a Thr
217 Thr
221 Thr
247 motif (low virulent motif).
Santi et al [19] suggested that the Ala-to-Thr substitution
at position 221 in VP2 is a molecular determinant for the
establishment of a persistent IPNV infection. Thus, we
have analyzed the IPNV VP2 nucleotide composition in
virus recovered from fish head kidney during the infection.
Comparing sequences to the input strains could provide
information about the rate and character of virus changes
in vivo.
Results
Two isolates of IPNV gave divergent mortality rates in a
bath challenge
Before initiation of this challenge, head kidney from 10
fish was sampled and checked for the presence of IPNV
by carrier tests in pools of 3 individuals. The lower detec-
tion limit was 0.88 virus particles g
-1 tissue. No IPNV
positive pools were found. In the bath challenge study,
mortality caused by IPNV was initiated 12 days post
infection (d p.i.) with the NFH-Ar isolate and there was a
rapid increase in mortality until day 21. The experiment
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one week after the fish in both groups had ceased to die.
At that point, fish infected with the NFH-Ar isolate
showed far higher cumulative mortality (38.1%, average
of two tanks) compared to the NFH-El isolate which gave
only 1.6% cumulative mortality on average (Figure 1A).
No mortality was observed among the control fish.
Virus quantification in pancreas and head kidney
The pancreatic tissue was used for quantification of
virus as it is one of the primary target organs for IPNV
replication. The viral titer was determined as infectious
particles per gram tissue from 6 fish infected with each
isolate at day 6, and from 8 fish at day 13 and 29. Viral
titers increased for both isolates from day 6 to day 13,
although for NFH-El (low-mortality groups) the replica-
tion was slower compared to NFH-Ar (high-mortality
group). A further increase in titer from day 13 to day 29
was observed for NFH-El, whereas NFH-Ar showed
decreased titers at 29 d p.i. (Figure 1B). The number of
NFH-Ar infectious particles was 3.4 × 10
3/g in average
at day 6, increased to 2.2 × 10
8 at day 13 and dropped
to 8.5 × 10
5 by the third sampling at day 29. Whereas
the number of infectious particles for the NFH-El isolate
was slightly higher at the first sampling (average 1.6 ×
10
4/g), only increasing to 3.3 × 10
4 at day 13 and further
leaps to 6.4 × 10
7 a td a y2 9 .T h ei n d i v i d u a lv a r i a t i o n
was greater in the groups infected with NFH-El than the
NFH-Ar infected groups.
The levels of IPNV VP2 RNA in the head kidney of
NFH-Ar and NFH-El challenged fish were quantified by
qPCR during the time-course. We calculated the relative
quantity of VP2 by comparing the expression levels in
the different samples to NFH-El sampled at 29 d.p.i.
Figure 1 Cumulative mortality and presence of IPN virus in pancreas and head kidney of Atlantic salmon challenged with two
different IPNV strains. A. Percent cumulative mortality is significantly higher in fish infected with NFH-Ar (tank I and tank II indicated with dark
and light blue, respectively) than with NFH-El (two tanks indicated with orange or yellow) after bath challenge. B. Viral titers in pancreas from 3-
4 fish in duplicate tanks at day 6, day 13 and day 29 post challenge, measured by TCID50/g tissue. C. IPNV VP2 transcript levels relative to levels
of NFH-El 29 d.p.i in head kidney measured by qPCR. D. IPNVVP2 Ct-values measured in head kidney from individual fish at day 13 and day 29.
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the two infected groups at 6 d p.i. The qPCR results for
other time-points were overall in agreement with the
viral titers determined in pancreas samples from the
infected fish. The group infected with NFH-Ar had pre-
valence of 100% (7/7) at day 13 p.i. with an average
1000 fold higher VP2 RNA load to NFH-El 29 d p.i;
w h i l ea td a y2 9p . i .t h ep r e v a l e n c ew a s5 7 %( 4 / 7 )a n d
VP2 RNA levels were approximately 7 fold higher com-
pared to NFH-El 29 d p.i. (Figure 1C, D). For NFH-El a
decrease in IPNV VP2 RNA levels was observed from
13 d p.i. to 29 d p.i. in head kidney. At day 13 d p.i. the
prevalence was 100% (8/8) for NFH-El (2 fold higher
virus load than 29 d p.i.), while at day 29 it had
decreased to 37.5% (3/8)
Sequence comparison of the viral genes
The sequences encoding the individual viral proteins
were determined for each of the isolates to evaluate the
rate and character of changes and to search for the differ-
ences associated with virulence. The virus isolates were
sequenced at several stages of the experiment: initially
after the field outbreaks, then after propagating the virus
in the CHSE-214 cell-line, before the challenge and
finally, in the infected fish. The rate of sequence changes
was lowest in VP4 (7.4 sites/kb) being 2-2.7 times greater
in other genes (Table 1). VP1 showed a higher rate of
synonymous (silent) substitutions (Ka/Ks = 0.03). For
VP2 and VP3 the non-synonymous (amino-acid replace-
ment) nucleotide substitution rate was much higher (one
order of magnitude greater in VP2 and VP3), and its dis-
tribution along the sequences strongly suggested pre-
sence of hyper variable regions (HVR). Importantly, the
first of two HVRs of VP2 with the highest level of Ka/Ks
(Figure 2) coincided with the region that is regarded as a
determinant of virulence [8,19]. All mutations in VP5
produced premature stop codons. The deduced amino
acid sequences for VP2 and VP5 from the two isolates
were aligned to each other and to the reference strain N1
before and after the challenge (Figure 3A, B, C and 3D).
After sampling from the original field outbreaks (which
were reported to give 32% mortality for the NFH-Ar
and 5% mortality for the NFH-El isolate) the isolates
were passaged once in CHSE-214 cells before sequence
analyses. The VP2 sequences revealed a Thr
217-Ala
221-
Thr
247 motif in both isolates (origin) (Figure 3A, B and
3C). Originally, sequencing of VP5 NFH-Ar gave an ORF
resulting in a 133 amino acid protein (15.2 kDa pre-
dicted), whereas VP5 from NFH-El had a premature
stop-codon resulting in a very short ORF, encoding only
28 amino acid residues (3.3 kDa predicted) (Figure 3A
and 3D). In the course of this study sequence changes in
VP2 and VP5 accumulated continuously, during passage
in culture and infection in the fish (Figure 3A). In order
to obtain sufficient amount of virus to perform the bath
challenge, the isolates were passaged additional times in
CHSE-214 cells (2x for NFH-Ar and 3x and NFH-El).
Sequencing of this material (challenge input) revealed a
change into a Thr
217-Thr
221-Thr
247 motif in VP2 for the
NFH-El and a partial shift from Ala
221 to Thr
221 in NFH-
Ar (Figure 3A, B and 3C). Additionally a partial shift
from an Arg (R) in position 106 of VP5 to a stop-codon
in this position was observed in NFH-Ar (Figure 3A and
3D). After the challenge viral RNA/cDNA from the head
kidney of infected fish (n = 8) was sequenced and
the VP2 motifs changed into Pro
217-Ala
221-Ala
247 in
both isolates during the infection process in the fish
(Figure 3A, B and 3C). VP5 in NFH-Ar acquired a stop-
codon in position 106, resulting in a 12.1 kDa protein,
whereas NFH-El maintained it’ss h o r t( 3 . 3k D a )V P 5
(Figure 3A and 3D).
Gene expression
Microarray analyses revealed 211 differentially expressed
genes, of which 81 and 130 genes responded to both iso-
lates or to only NFH-Ar respectively; we did not find genes
that were regulated exclusively in the NFH-El infected
salmon. Both isolates affected genes within different func-
tional groups. Equal down-regulation was observed in
genes encoding motor proteins (myosins, tropomyosins,
troponins), plasma proteins (plasminogen precursor, coa-
gulation factor X, angiotensin I converting enzyme) and a
suite of enzymes involved in xenobiotic metabolism and
detoxification (Additional file 1). Similar changes were seen
in immune related genes implicated in different processes
(Table 2). It is worth noticing that genes involved in bio-
synthesis of eicosanoids, the inflammatory regulators of
lipid origin and several complement factors are down-regu-
lated. At the same time the virus responsive genes (VRG)
were up-regulated only in fish infected with NFH-Ar.
Some VRGs have well established roles in antiviral
responses: antigen presentation (beta-2 microglobulin,
MHCI, proteasome subunit), signal transduction down-
stream of IFN (Jak, STAT) and editing viral RNA (double-
stranded RNA-specific adenosine deaminase - ADAR);
several more genes are known as IFN-dependent. This
group also includes genes with undetermined functions,
which however have shown consistent induction in other
virus infection studies that used the same microarray
Table 1 Mutation rates in IPNV genome
VP1 VP2 VP3 VP4 VP5
Length bp 2535 1521 710 679 402
Mutations per 1 kb 14.6 15.8 19.7 7.3 17.4
Non-synonymous mutations 3 12 9 2 7
Synonymous mutations 33 12 5 3 0
Ka/Ks 0.03 0.36 0.40 0.17
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galectins and galectin binding protein, a tripartite motif
protein and SRK2-like tyrosine kinase. Six immune genes
were chosen for verification of microarray analyses and
results produced with two independent methods were in a
good agreement (Figure 4A). At 13 d p.i. significant up-
regulation was observed only in salmon challenged with
NFH-Ar. At 29 d p.i. expression changes were smaller with
no difference between the isolates. The greatest expression
changes were seen in SRK2.
The expression of selected immune genes not presented
on the microarray was analyzed by qPCR (Figure 4B, C).
The TLR8, 9, 22, RIG-I, MDA5 and PKR are implicated
in viral detection [30,38] and MyD88 is a TLR adaptor
signaling molecule [27]. Interestingly, all these nucleic
acid recognition molecules were slightly down-regulated
at 6 d p.i. in both infected groups (Figure 4B). At the
later time-points, TLR22 did not show difference
between the infected fish and controls. PKR was down-
regulated in the infected fish both at day 6 and day 29
p.i., while a modest but significant (p < 0.05) increase in
PKR levels could be detected at day 13 p.i for the NFH-
El isolate. The remaining PRRs tested had expression
profiles that were similar to those observed in other
VRG (Figure 4A, C). TLR8 was up-regulated in NFH-Ar
infected fish at both time-points which was significant
(p < 0.05) for 13 d p.i, while expression change of TLR9
was significant (p < 0.05) at 29 d p.i. The cytoplasmic
RNA sensors RIG-I and MDA5 showed 5-fold induction
at 13 d p.i. in the NFH-Ar group which was significant
(p < 0.05) for RIG-I. MDA5 also showed a large increase
at 29 d p.i. in two individuals infected with NFH-El.
The antiviral genes Mx and IFN-g (type II IFN) were
the most highly induced transcripts in the study, and
the NFH-Ar infected fish showed the greatest expression
changes at 13 d p.i.; 280-fold for Mx and a significant
(p < 0.05) 13-fold for IFN-g (Figure 4C). Their expres-
s i o nl e v e l sd e c r e a s e da t2 9dp . i .t o1 3 -a n d3 - f o l du p -
regulation respectively (Figure 4C). In the NFH-El group
Mx and IFN-g showed highest expression at day 29 p.i.
with 29- and 5-fold up-regulation respectively. As illu-
strated in Figure 5, exemplified by Mx and IFN-g,t h e r e
were variations in immune gene expression between
individuals in both groups. Nevertheless, for most indi-
viduals the immune gene expression mirrored the virus
levels, both the IPNV titers in pancreas and VP2 tran-
script levels in head kidney. Three type I IFN genes had
different expression profiles during the challenge. While
IFN-c did not respond to infection, IFN-a1 showed a
moderate up-regulation both at day 13 (3.5-fold) and
day 29 p.i. (2.5-fold) in NFH-Ar group, and at day 29 p.
i. in the NFH-El group (5.9 fold). Expression of IFN-b in
the head kidney was consistently low or undetected;
however, an induction was observed at 13 d p.i. in three
of eight NFH-Ar-infected fish (results not shown).
Secreted IgM was slightly up-regulated at 29 d p.i for
both isolates at similar levels (about 3-fold).
Discussion
IPNV isolates have been reported to vary considerably
in their virulence and pathogenicity for Atlantic salmon
[18,19]. Previous studies have indicated that a combina-
tion of IPNV virulence and host pathogen interactions
determines the outcome of IPNV infections. Occurrence
of multiple strains indicates rapid changes of the virus
but little is known about the rate and character of muta-
tions. It also remains undefined if susceptibility of sal-
mon to IPNV could be associated with low or excessive
AB
Figure 2 The highest level of sequence changes in VP2 coincided with the region that is regarded as a determinant of virulence. A.A
sliding window plot of mutation frequencies, and B. Ka/Ks ratio in VP2 (window length - 50 sites, step size - 10 sites).
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Page 5 of 14Figure 3 Sequence analyses of IPNV segment A. A. A schematic presentation of the IPNV genome segment A which encode VP2, VP4, VP3
and VP5. Positions of divergent amino acid are indicated, and the sequences of VP2 and VP5 from the two field isolates NFH-Ar and NFH-El are
compared to the non-virulent lab-strain N1 before and after the challenge experiment. B. Sequencing chromatograms showing that amino acids
in positions 217, 221 and 247 of VP2 were changing rapidly in cell culture and in challenged fish. The PCR-products sequenced from the NFH-Ar
strain changed partially from a TAT motif found in the originally infected fish (origin) to a TTT motif after propagation in CHSE-214 cells for the
challenge experiment (input). Virus isolated from the fish after the challenge had a PAA motif (HK d13). C. The NFH-El strain changed from a TAT
found in the original material (origin) to a TTT motif after three passages in CHSE-214 cells (input). Virus isolated from the fish after this challenge
(HK d29) had a PAA motif like seen in the NFH-Ar challenged fish. D. The ORF of VP5for the NFH-Ar strain changed from a 133 amino acid
peptide to a 105 amino acid peptide when a stop codon was introduced in position 106 after the challenge. The NFH-El strain initially had a
very short VP5 ORF, only 28 amino acids long, which was maintained after the challenge.
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Page 6 of 14Table 2 Differentially expressed immune genes between IPNV isolates, as assessed by microarray analyses of head
kidney at 13 d p.i.
Accession Gene Isolate NFH-Ar Isolate NFH-El
Virus responsive
GE828737 Beta-2 microglobulin BA1 1.46 ± 0.21 0.31 ± 0.19
CX026208 Beta-2-microglobulin JB1 1.27 ± 0.24 0.37 ± 0.12
CA043257 MHC class 1b antigen 0.91 ± 0.17 0.16 ± 0.12
CU070775 MHC class I heavy chain-1 0.98 ± 0.19 0.21 ± 0.07
BX857730 Proteasome subunit beta type 9 0.62 ± 0.09 0.10 ± 0.03
CU071943 Galectin 9-1 0.60 ± 0.17 -0.06 ± 0.13
CX035552 Galectin 9-2 1.50 ± 0.44 0.03 ± 0.11
CA353586 Galectin 9-3 2.33 ± 0.41 0.47 ± 0.10
CA379576 Galectin like 2 1.14 ± 0.31 0.19 ± 0.12
CA379898 Galectin like 1 1.34 ± 0.39 -0.24 ± 0.09
BX079375 Galectin-3 binding protein 1.83 ± 0.25 0.21 ± 0.17
CA367930 Interferon inducible protein 1 0.76 ± 0.17 0.58 ± 0.21
CA363130 Interferon-induced 35 kDa protein 0.75 ± 0.23 -0.03 ± 0.06
CA376422 Interferon-induced protein 44-2 0.70 ± 0.16 0.17 ± 0.08
CA381440 Double-stranded RNA-specific adenosine deaminase 0.70 ± 0.16 0.11 ± 0.09
CA378782 Tyrosine-protein kinase Jak1-2 0.99 ± 0.31 -0.28 ± 0.13
CA373850 STAT1 1.11 ± 0.22 0.02 ± 0.11
CA376536 Tripartite motif (VRG3) 1.68 ± 0.19 0.41 ± 0.12
CA349577 Tyrosine-protein kinase SRK2 1.85 ± 0.57 -0.32 ± 0.10
Chemokines, cytokines, receptors and transducers
CA361535 CC chemokine SCYA106 1.64 ± 0.40 0.03 ± 0.12
CA366435 CC chemokine SCYA110-1 -0.91 ± 0.10 -0.77 ± 0.08
CA374135 CCL4 -0.78 ± 0.09 -0.78 ± 0.12
CA378286 Interleukin-1 receptor-associated kinase 1-2 0.71 ± 0.15 0.78 ± 0.13
CA362179 Interleukin-1 receptor-like protein 2 0.85 ± 0.21 -0.37 ± 0.12
CA361101 Regulator of G-protein signaling 1-2 0.81 ± 0.18 0.52 ± 0.22
CF752495 Transcription factor jun-B-1 0.59 ± 0.13 -0.18 ± 0.10
CA342573 TNF receptor superfamily member 11B 1.48 ± 0.31 0.10 ± 0.14
Eicosanoid metabolism
CA346166 Arachidonate 5-lipoxygenase-1 0.59 ± 0.07 0.78 ± 0.14
BX890112 Cytochrome P450 2F1 -1.03 ± 0.04 -0.94 ± 0.11
EV384586 Cytochrome P450 2K4 -1.08 ± 0.07 -1.06 ± 0.19
CA372428 Leukotriene B4 receptor 1 -0.98 ± 0.10 -1.04 ± 0.12
CA366643 Prostaglandine D synthase -1.13 ± 0.20 0.28 ± 0.21
Complement, lectins, effectors
CA359451 C type lectin receptor C -0.72 ± 0.05 -0.65 ± 0.17
CA363676 Complement factor B/C2-B -0.96 ± 0.08 -0.88 ± 0.11
BX082584 Complement factor H-1 -0.92 ± 0.07 -0.61 ± 0.12
BX075495 High affinity Ig Fc receptor I 0.93 ± 0.29 0.20 ± 0.15
CA367288 Properdin 1.02 ± 0.16 0.89 ± 0.15
CA376803 Serine protease-like protein-2 -0.68 ± 0.15 -0.21 ± 0.15
CR943302 Tolloid-like protein (nephrosin)-1 -0.44 ± 0.11 -1.08 ± 0.30
CA370329 Lysozyme C precursor 0.71 ± 0.13 -0.04 ± 0.09
CA385270 Granulins 0.73 ± 0.14 0.25 ± 0.02
CF752659 Ferritin heavy chain-1 0.82 ± 0.12 0.56 ± 0.24
CA345780 Lysozyme g-2 -0.90 ± 0.10 -0.49 ± 0.36
Apoptosis, cell cycle
CX720700 BCL2/adenovirus E1B protein-interacting 1.49 ± 0.29 0.93 ± 0.19
CA366608 CASP8 and FADD-like apoptosis regulator 1.09 ± 0.11 0.63 ± 0.14
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isolates of IPNV with marked difference in mortality
were applied for experimental infection of Atlantic sal-
mon. For the first time the sequence changes and
immune responses to low and high virulence strain were
compared within a single challenge test.
Previous studies have identi f i e dt h eo u t e rc a p s i dp r o -
tein VP2 as the main determinant of IPNV virulence as
it comprises all the neutralizing epitopes and cell attach-
ment sites that determine host or cell specificity [15].
The amino acid signature associated with virulence of
different strains is also identified within the VP2 region
[8,19,39]. The sequences of the two isolates in this study
were determined before and after the challenge. Initially
NFH-Ar had Thr
217-Ala
221-Thr
247 while NFH-El had
Thr
217-Thr
221-Thr
247, implying high and low virulence
of NFH-Ar and NFH-El respectively (Figure 3A). Thus
the results from this study are in accordance with pre-
viously reports of the virulence motifs within VP2 [19].
Rapid changes were seen during passage in cell culture
and also during infection in the fish. After the challenge
both isolates acquired Pro
217-Ala
221-Ala
247 motif in VP2
associated with the moderate to low virulence [19].
Sequence analyses revealed a remarkably high rate of
non-synonymous substitutions in the HVR containing
the virulence motif. Commonly, high Ka/Ks ratios point
to the divergent selection meaning that sequence
changes increase the rate of reproduction. However in
this study we observed accumulation of mutations that
correlated with a reduction in virus proliferation, thus
being favorable for the fish. End of mortality in NFH-Ar
group coincided with the loss of the high virulence
motif. To explain this finding, virus modification as the
host’s defense mechanisms can be hypothesized. Virus
editing is a rapidly expanding research area. At present,
the best studied actors are adenosine deaminases
(ADARs) that target regions of dsRNA, converting ade-
nosine (A) to inosine (I) resulting in an A to guanosine
(G) change after second strand synthesis [40]. ADARs
target mRNAs, transposable elements and RNA viruses’
genomes. In mammals, several families of viruses show
A to G mutations thought to be caused by ADARs [41].
The induction of ADAR in the NFH-Ar infected fish
observed in the microarray in this study might indicate
a possible role for ADAR in editing IPNV. Most of the
changes observed in our study, disregarding whether
Table 2 Differentially expressed immune genes between IPNV isolates, as assessed by microarray analyses of head
kidney at 13 d p.i. (Continued)
CA384134 G1/S-specific cyclin D2 1.98 ± 0.41 -0.12 ± 0.31
CA377697 Platelet-derived endothelial cell growth factor 0.72 ± 0.15 0.47 ± 0.09
CA376673 Pre-B cell enhancing factor 1.47 ± 0.34 0.28 ± 0.11
Data are log2-ER ± SE. Significant difference between the study groups (t-test, p < 0.05) is indicated with italics.
A
B
C
Figure 4 Regulation of immune pathways in response to
infection with the two IPNV isolates analyzed by qPCR. Data are
mean fold change in head kidney transcript levels +/- SE from
infected fish relative to controls calculated by the ΔΔCT method,
adjusted for PCR efficiency and normalized against the elongation
factor. A. Validation of microarray results by qPCR on selected
immune genes presented in Table 2 (n = 6). B. Expression of
pattern recognition receptors, MyD88 and PKR analyzed in 8 fish per
strain at each time point. C. Expression of genes involved in innate
immunity/IFN signaling and sIgM analyzed in 8 fish per strain at
each time point.
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from T to C (or vice versa) associated with deamination
(results not shown). However, whether the mutations in
IPNV detected in this study are caused by salmon
ADARs is an interesting question that needs to be
addressed in future studies.
T h et w ov i r u si s o l a t e su s e di nt h i ss t u d ys h o w e d
greater discrepancies in the VP5 region than previously
described isolates. The change of VP5 into a shorter pro-
tein in the NFH-Ar infected fish might imply a more
benign virus since the longer 15.2 kDa VP5 protein was
shown to have a potential antagonistic effect on the IFN
response by inhibiting IFN-induced expression from the
Mx promoter [34] and might thereby benefit the viral
replication. However, the domains responsible for this
function have not been mapped and can still be present
in the shorter 12.1 kDa version. An early stop-codon
located in NFH-El leaves this isolate with a severely trun-
cated form of VP5, only 28 amino acids long, and to our
knowledge such a mutation has not been reported in
other surveys of IPNV field isolates. It has been suggested
that VP5 has an anti-apoptotic function, which is prob-
ably not essential for the virulence or persistence of the
virus [42,43]. Functional significance of the observed
changes in VP5 remained unclear. The amino acid
sequences of VP1 ORF were identical between the two
isolates throughout the study and VP4 were subject to
very few mutations.
The mortality rates associated with the structural dif-
ferences described above may be linked to the ability of
virus to invade and replicate within the host cells and/or
the scale and character of immune responses. Associa-
tion between mortality and the virus titers was obvious
(Figure 1). NFH-El characterized with low replication
was avirulent while NFH-Ar infection was fatal at high
rate of proliferation at 13 d p.i. To assess the immune
responses, we used expression profiling with microarray
and qPCR analyses of genes with well-established roles
(IFNs, Mx and PRRs) and both approaches produced
similar results. The expression levels of VRGs were
apparently mirroring the viral titers and expression
levels of the IPNV VP2. At 13 d p.i. VRG were induced
in salmon infected with NFH-Ar but not with NFH-El
consistently with the difference of virus titers. Up-regu-
lation of VRG in NFH-E1 infected fish at 29 d p.i. was
in line with the slight increase of virus titer and did not
affect mortality. It is likely that the slower replication
and concomitant slower spread of the NFH-El strain
may allow time for a systemic induction of the host
anti-viral system, including adaptive responses.
The IFN system is believed to have a crucial role in the
first line of defense against virus infections, and in vitro
studies have demonstrated that IPNV replication in cell
cultures is efficiently inhibited by salmon IFN-a1 [21,22].
Additionally, injection of synthetic IFN-inducers like
CpG and poly I:C induce protection against IPNV in
Atlantic salmon [44]. In this study IFN-a1 was induced
by both viral strains and major up-regulation was seen in
the IFN-a1 dependent gene Mx. IFN-c, was not induced
and even slightly down-regulated at 29 d p.i. for NFH-Ar.
IFN-c is suggested to have a separate regulation from a
and b and can be produced by a different cell population
than IFN-a1 [20]. IFN-b was not detected in this study or
showed consistently low expression levels (data not
shown). Despite the suggested role of type I IFN in
restraining virus production, results in our lab has
demonstrated that IFN-a1 does not completely inhibit
IPNV growth but causes a delay in viral protein synthesis
[34]. Furthermore, our data suggest that IPNV-encoded
proteins may be involved in weakening of IFN signaling
Figure 5 Variations in immune gene expression and virus levels between individuals. Transcript levels of Mx, IFN-g and IPNV VP2 in head
kidney and titers of IPNV in pancreas are shown at individual levels for the two IPNV isolates. The Mx and IFN-g transcript levels are compared
to uninfected control fish, while IPNV VP2 transcripts are compared to the NFH-El group 29d.p.i, IPNV titers were calculated by end point titration
and results show TCID50/g tissue. For some individuals the transcript levels were undetected and are thus not presented.
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the activity of IFN-induced genes, thus the higher repli-
cation rate of NFH-Ar compared to NFH-El may cause a
more potent IFN-antagonizing effect of the NFH-Ar
strain. However when interpreting the results from live
pathogen challenges, it is important to keep in mind the
complexity of such studies, where it is not straight for-
ward whether an observed response is a strategy
employed by the virus for its own benefit or a response
by the host to control the virus.
Although innate immunity by itself represents a power-
ful system to combat viral invaders, many infections can
only be cleared in combination with adaptive immunity.
In this regard type I IFNs are known to promote the
adaptive arm including both T cell mediated cellular
responses and antibody production [45,46]. It is likely
that the reduction of virus titers by 29 d p.i. could be
associated with the onset of adaptive immune responses.
Unlike the genes implicated in the innate immunity,
sIgM showed no expression changes at 13 d p.i. and was
slightly induced at 29 d p.i.
Results of this study added knowledge to the under-
standing of the immune responses after IPNV infections.
Expression of a panel of PRRs was assessed including sev-
eral recently identified genes. TLR8, 9 RIG-I and MDA5
showed up-regulation and followed the same trend as
other immune genes. Earlier we observed a modest
increase of TLR8 and 9 expression during stimulation
and infection [27,28]. TLR22 is reported to recognize
dsRNA in pufferfish and when over-expressed it induces
type I IFN expression upon IPNV infection, which sug-
gests a possible role for TLR22 in protection against
IPNV [30]. However, TLR22 was not induced by IPNV in
this study. Unexpectedly, PKR, an IFN-inducible gene,
was down-regulated at all time points except 13 d p.i.
(Figure 4A). This was in contrast to Mx, another IFN-
inducible gene and IFN-a1, which were up-regulated.
Functional studies of salmon PKR have to our knowledge
not been reported, however flounder PKR was up-regu-
lated both in vitro and in vivo b yan e g a t i v es i n g l e
stranded RNA virus (SMRV), which also induced Mx
expression in vitro [47]. PRRs, PKR and MyD88 were
down-regulated at 6 d p.i. in both study groups. This
could be explained by migration of leukocytes expressing
the PRRs from the head-kidney into the bloodstream at
early time-points of the infection.
IFN-g was together with Mx the most highly induced
immune gene in this study, and high levels of IFN-g has
been reported in other IPNV challenge experiments
[31]. IFN-g is regarded as a typical Th1 cytokine which
bridges the innate and adaptive immune responses. Fish
IFN-g share several functional properties with mamma-
lian IFN-g including macrophage activation [48-50] and
rainbow trout IFN-g is shown to signal through STAT1
[50,51]. Recently, we have observed antiviral activity
against IPNV by IFN-g, although the effect was not as
pronounced as described for IFN-a1 [52]. Like in mam-
mals, fish IFN-g plays diverse roles in different facets of
the immune system, and the increased levels of IFN-g
upon IPNV challenge detected here suggest anti-IPNV
activity.
Conclusions
Our study aimed at investigation of different mortality
associated with two IPNV isolates. High incidence of
death of NFH-Ar infected salmon was in line with the
initial presence of the virulence motif in VP2 and higher
virus titers in the head kidney and pancreas compared to
NHF-El. PPRs, IFNs and ISGs were induced to a higher
magnitude by the high virulent strain NFH-Ar and corre-
lated with the viral load in the head kidney. Subsequent
decrease of virus titers and mortality could be due to the
sequence changes in the hyper variable regions of IPNV
together with the development of acquired immunity in
fish.
Methods
Virus isolates
Two IPNV isolates, referred to as NFH-Ar and NFH-El,
collected from field outbreaks of IPN in 2004 were used
in this study. Veterinarians had diagnosed IPN based on
clinical observations and by use of an agglutination assay
(Phadebact coating kit, Boule Diagnostics AB). The
NFH-Ar isolate, obtained from an IPN outbreak in Frøya,
Norway in 2004, was reported to give 32% mortality,
while the NFH-El, obtained from an IPN outbreak in
Alta, Norway in 2004, was reported to give 5% mortality.
Head kidney samples collected during these outbreaks
were sent to our lab and tissue homogenates were made
and inoculated on CHSE-214 cells for propagation and
sequencing. For NFH-Ar a second, and for NFH-El a
third cell-culture passage of the virus strain was used in
the present experiment. The input strains were
sequenced before challenge.
IPNV challenge of Atlantic salmon
The challenge was carried out at Tromsø Aquaculture
Research Station (Tromsø, Norway). Non-vaccinated
Atlantic salmon, Salmo salar L., strain Aquagen IPNV
sensitive (Aquagen, Kyrksæterøra, Norway), with an aver-
age size of 51 g, was used for the challenge two days after
transfer to seawater. Bath challenge was performed as
described by Johansen and Sommer [53] using an infec-
tious dose of TCID50/ml = 5 × 10
5 of the field isolates
NFH-Ar and NFH-El. Two parallel tanks supplied with
200 L of 10°C seawater were used for each isolate. Each
tank contained 70 fish and a separate tank was used for
70 uninfected control fish. The fish were fed daily on
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after challenge.
Sampling
Mortality was monitored throughout the experiment by
counting dead fish. An IPNV rapid agglutination kit (Pha-
debact coating kit, Boule Diagnostics AB) was used on
head kidney samples from dead fish to verify IPN as the
cause of death. Percent cumulative mortality in infected
fish was calculated compared to control fish using Graph-
Pad Prism 4.0 tool for statistical analyses. Sampling was
performed on surviving fish. Pancreatic tissue and head
kidney were aseptically removed from 4 fish in each tank
at 6, 13 and 29 d p.i. Pancreatic tissue was stored in L-15
medium on ice until frozen at -80°C, whereas head kidney
samples were stored in RNAlater
® (Ambion) at -80°C.
Quantification of IPNV by titration
Pancreatic tissue was homogenized using an Ultra Thur-
rax T25 basic crusher (IKA-WERKE). Homogenized tis-
sue was diluted to 5% in Eagle’s minimum essential
medium (EMEM) (Gibco) supplemented with 100 μg/ml
streptomycin, 60 μg/ml penicillin, 2 mM L-glutamine
and 1% non-essential amino acids, before centrifuged at
15000 × g for 5 min at 4°C. Homogenates were inocu-
lated onto CHSE-214 cells in 96 wells plates at a start-
ing concentration of 0.5% (w/v). Individual viral titers
were determined by end-point titration using 10-fold
dilutions and 2 replicates and calculated by the TCID50
method [54].
RNA isolation and cDNA synthesis
For analyses of cellular and viral gene expression total
RNA from head kidney sampled from 8 challenged and 4
control fish at each time point, was isolated using a com-
bination of Trizol and PureLink RNA Kit (Invitrogen).
RNA quality was assessed on an agarose gel and the
quantity determined by NanoDrop 2000 spectrophoto-
metry (Thermo Scientific). No RNA degradation was
observed. After isolation, the RNA was DNase treated
applying TURBO DNase (Ambion). cDNA was synthe-
sized in a 25 μl reaction from 200 ng DNase treated total
RNA primed with random hexamers (TaqMan Reverse
Transcription Reagents kit, Applied Biosystems). The
manufacturer’s protocol was followed. For isolation of
viral RNA after passage in cell culture QIAamp Viral
RNA Mini Kit (Qiagen) was used according to the manu-
facturer’s instructions.
Sequencing of virus isolates
Each virus isolate was sequenced from virus derived
material under the following conditions; origin (virus
homogenates from head kidney pooled from 2 fish in
field outbreak passaged 1× in cell culture), input (virus
homogenates from head kidney pooled from 2 fish in
field outbreak passaged 2-3× in cell culture), during
infection(head kidney from day 13 (NFH-Ar) or day 29
(NFH-El) infected fish, 8 pooled individuals from each
group). Primers specific for each of the genes encoding
the five IPNV proteins were used to amplify the indivi-
dual genes (from head kidney cDNA pooled from 8 fish
or cDNA obtained from head kidney virus homogenates
from 2 fish passaged in cell culture) in a PCR reaction
using Pfu Turbo Hotstart DNA polymerase (Stratagene).
The PCR-products were sequenced in both directions
using the same primers and BigDye3.1 chemistry and a
3100 gene analyzer. The sequences were aligned with
BioEdit 7.0.5 [55] and DnaSP V5 [56] was used for eva-
luation of mutation rates and search for HVR.
Microarray analyses
Microarray analyses were performed at 13 d p.i. on head
kidney samples of salmon infected with isolates NFH-Ar
and NFH-El (5 individuals from each group, one micro-
array per individual). The salmonid fish microarray (SFA
2.0 or immunochip, Geo Omnibus GPL6154) contains
1800 unique clones printed each in 6 spot replicates.
Pooled samples of uninfected salmon (equal amounts of
RNA, n = 4) were used as a common reference. Test and
reference RNA (10 μg) were labeled with the fluorescent
dyes Cy5-dUTP and Cy3-dUTP respectively (Amersham
Pharmacia), which were incorporated in cDNA using the
SuperScript™ Indirect cDNA Labeling System (Invitro-
gen). Synthesis of cDNA was performed at 46°C for
3 hours in a 23 μl reaction volume, following RNA degra-
dation with 2.5 M NaOH at 37°C for 15 min and alkaline
neutralization with 2 M Hepes. Labeled cDNA was com-
bined and purified with Microcon YM30 (Millipore).
Microarray slides were pre-treated with 1% BSA fraction
V, 5× SSC and 0.1% SDS for 30 min at 50°C and then
washed with 2× SSC (3 min) followed by 0.2× SSC
(3 min) at room temperature and hybridized over-night
at 60°C in a cocktail containing 1.3× Denhardt’s, 3× SSC,
0.3% SDS, 0.67 μg/μl polyadenylate and 1.4 μg/μl yeast
tRNA. After hybridization slides were washed at room
temperature in 0.5 × SSC and 0.1% SDS (15 min), 0.5 ×
SSC and 0.01% SDS (15 min), 0.06 × SSC (2 min) and
0.06 × SSC (1 min). Scanning was performed with Gene-
Pix 4100A and images were processed with GenePix 6.0
(Molecular Devices). The spots were filtered by criterion
(I-B)/(SI+SB) ≥ 0.6, where I and B are the mean signal
and background intensities and SI,S B are the standard
deviations. Low quality spots were excluded from ana-
lyses and genes with less than 3 high quality spots on a
slide were discarded. After subtraction of median back-
ground from median signal intensities, the expression
ratios (ER) were calculated. Lowess normalization was
performed first for the whole slide and next for twelve
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performed in two stages. First, technical accuracy was
assessed by difference of log2-ER from zero in six spot
replicates and genes with significant changes (Student’s
t-test, p < 0.05) in at least 3 of 5 individuals per group
were selected. Next, analysis of biological replicates was
carried out and differential expression was assessed by
the mean fold change (> 1.5) and difference from control
(one sample t-test, p < 0.05).
Quantitative real-time RT PCR (qPCR) analyses
PCR primers used with Sybr Green assay were designed
using Vector NTI (Invitrogen) and synthesized by Invi-
trogen (table 3). The amplicon lengths set to be between
50 and 200 bases were checked on 1.5% agarose gel.
TaqMan assays employing a hydrolysis probe were
designed using Assays-by-design (Applied Biosystems)
and synthesized by Applied Biosystems. PCR efficiency
was calculated from tenfold serial dilutions of cDNA for
Table 3 Primers and probes used for qPCR analyses
Genes Assay Primer Sequence (5’-3’) PCR efficiency GenBank accession #
EF1aB TaqMan Forward
Reverse
Probe
TGCCCCTCCAGGATGTCTAC
CACGGCCCACAGGTACTG
AAATCGGCGGTATTGG
2.0 BG933897
IFN-c TaqMan Forward
Reverse
Probe
TGGGCAGTGTGGATACAAGTG
CTGCAATGTTCCCAAAGTACGTATT
CTGTCCTGATGAGATAAT
2.0 EU735545
EU735547-50
IFN-a1 TaqMan Forward
Reverse
Probe
CCTTTCCCTGCTGGACCA
TGTCTGTAAAGGGATGTTGGGAAAA
CTTTGTGATATCTCCTCCCATC
1.94 AY2169594
AY2169595
IFN-g TaqMan Forward
Reverse
Probe
AAGGGCTGTGATGTGTTTCTG
TGTACTGAGCGGCATTACTCC
TTGATGGGCTGGATGACTTTAGGA
2.0 AY795563
Mx1/2 e/e TaqMan Forward
Reverse
Probe
GATGCTGCACCTCAAGTCCTATTA
CGGATCACCATGGGAATCTGA
CAGGATATCCAGTCAACGTT
2.0 U66475
U66476
MyD88 TaqMan Forward
Reverse
Probe
GACAAAGTTTGCCCTCAGTCTCT
CCGTCAGGAACCTCAGGATACT
CTGGTGCCCGGAGCAA
1.84 EF672332
TLR8 TaqMan Forward
Reverse
Probe
ACCAAAACCACTAATGACATCATCTTCA
TGGTGATGCCATCAGGTATGTTT
CTCAGTCGACGCTCCTC
1.7 FJ467615
TLR9 TaqMan Forward
Reverse
Probe
TCTATGGCTGGGATGTCTGGTA
CAGTTGTGAGTAGCCCTTGTGT
CAGCACCTGGAAGCAG
1.81 EF672331
TLR22 TaqMan Forward
Reverse
Probe
ATTTATCCCGGAATCCATGTATCACG
CCACAGTAGGCGATGTCTAACA
CCTCAAGATAAGGAAGAACAT
1.98 AM233509
VP2 (IPNV) TaqMan Forward
Reverse
Probe
GCCAAGATGACCCAGTCCAT
TGACAGCTTGACCCTGGTGAT
CCGACCGAGAACAT
2.0 AJ877117
Beta 2 microglobulin SybrGreen Forward
Reverse
TCGTTGTACTTGTGCTCATTTACAGC
CAGGGTATTCTTATCTCCAAAGTTGC
1,6 BX076608
Galectin-3 binding protein SybrGreen Forward
Reverse
CCAGACCAACAGTGTTCACTTCAGC
ACGTGAAAGACATACCTGCCCTCAC
1,84 BX079375
Galectin-9 SybrGreen Forward
Reverse
GTCCTGTCTATTGCCTTCTCCAACC
GGTTTCGTTGACCACTGTGTGGA
1,76 CU071943
MHC-IHC SybrGreen Forward
Reverse
CTGCATTGAGTGGCTGAAGA
GGTGATCTTGTCCGTCTTTC
1,72 CU070775
Pre-B cell ef SybrGreen Forward
Reverse
GACTTCAATTTCCTGCTGGCTA
CTGCTTGTAATGTGTGACCT
1.77 CA376673
RIG-I SybrGreen Forward
Reverse
GACGGTCAGCAGGGTGTACT
CCCGTGTCCTAACGAACAGT
1.97 DY714827
MDA5 SybrGreen Forward
Reverse
CAGAGGTGGGGTTCAATGAT
AGCTCGCTCCACTTGTTGAT
1.92 FN396357
PKR SybrGreen Forward
Reverse
TTCCTGCATGGACTTGACTG
GTGAGGAACCGGTGTTCTGT
1.87 BT046111
SRK2 SybrGreen Forward
Reverse
TAGACATGGCACCATGGACCCTC
GGGTTCTTCAGTGCAGACAGCCA
1.81 CA349577
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using 2× SYBR
® Green Master Mix (Roche Diagnostics)
in an optimized 12 μl reaction volume, using 1:10
diluted cDNA, with primer concentrations of 0.4-
0.6 μM. PCR was performed in duplicate in 96-well
optical plates on Light Cycler 480 (Roche Diagnostics)
under the following conditions: 95°C for 5 min (pre-
incubation), 95°C for 5 sec, 60°C for 15 sec, 72°C for
15 sec (amplification), 95°C for 5 sec, and 65°C for
1 min (melting curve). Forty cycles were performed.
Assays employing a hydrolysis probe was conducted in a
20 μl reaction using 2.5 μl 1:10 fold diluted cDNA as
template and 2× TaqMan Fast Universal PCR Master
mix (Applied Biosystems). The expression of mRNA was
measured in an ABI Prism 7500 FAST Cycler (Applied
Biosystems) and the amplification profile was: 95°C for
20 sec followed by 40 cycles of 95°C for 3 sec and 60°C
for 30 sec. PCR analyses of the SybrGreen assays for
RIG-I, MDA5 and PKR at 13 and 29 d p.i. was also per-
formed at the ABI Prism 7500 FAST Cycler. Relative
expression of mRNA was evaluated by ΔΔCT, adjusted
for PCR efficiency and normalized against the elonga-
tion factor (EF1AB). IPNV VP2 was undetected in con-
trol samples and at 6 d p.i., in order to calculate the
ΔΔCT values the average of the NFH-El infected fish
sampled at 29 d p.i was used as calibrator. Results were
analyzed with ANOVA followed with Newman - Keuls
test (p < 0.05). (See Table 1 for primers and probes
used in the qPCR assays).
Additional material
Additional file 1: Differentially expressed genes. The genes were
selected as described in Methods. The data provided represent the log2
(Expression ratios) in IPNV infected salmon and control.
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